[HTML][HTML] Sex-specific outcomes in cancer therapy: the central role of hormones
P Bakhshi, JQ Ho, S Zanganeh - Frontiers in Medical Technology, 2024 - frontiersin.org
Sex hormones play a pivotal role in modulating various physiological processes, with
emerging evidence underscoring their influence on cancer progression and treatment …
emerging evidence underscoring their influence on cancer progression and treatment …
Estrogen receptor regulation of the immune microenvironment in breast cancer
C McGuinness, KL Britt - The Journal of Steroid Biochemistry and Molecular …, 2024 - Elsevier
Breast cancer (BCa) is the most common cancer in women and the estrogen receptor (ER)+
subtype is increasing in incidence. There are numerous therapy options available for …
subtype is increasing in incidence. There are numerous therapy options available for …
[HTML][HTML] A review of therapeutic agents for breast cancer with potentially radiosensitizing properties
Z Zhang, D Lim, Z Feng - Radiation Medicine and Protection, 2024 - Elsevier
Breast cancer is the most frequently diagnosed malignant tumor in women worldwide and
the leading cause of cancer death. Radiotherapy for breast cancer is readily accepted and …
the leading cause of cancer death. Radiotherapy for breast cancer is readily accepted and …
[HTML][HTML] Biological mechanisms of resistance to immune checkpoint inhibitors and overcoming this resistance: Challenges in medical oncology
Y Moskalenko - Regulatory Mechanisms in Biosystems, 2024 - medicine.dp.ua
Immune checkpoint inhibitors have opened up new possibilities in clinical oncology.
Monoclonal antibodies have shown their high clinical efficiency. They block CTLA-4, PD-1 …
Monoclonal antibodies have shown their high clinical efficiency. They block CTLA-4, PD-1 …